Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

BACKGROUND: Population-based studies suggest that emergency department visits and hospitalizations are common among patients receiving chemotherapy and that rates in routine practice are higher than expected from clinical trials. Chemotherapy-related toxicities are often predictable and, consequentl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Krzyzanowska, Monika K., Julian, Jim A., Powis, Melanie, Howell, Doris, Earle, Craig C., Enright, Katherine A., Mittmann, Nicole, Trudeau, Maureen E., Grunfeld, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6729066/
https://ncbi.nlm.nih.gov/pubmed/31488084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6099-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados